Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
30.09.25
/
50%
€10.60
Target price
30.09.26
€23.89
Performance (%)
11.32%
Price
28.04.26
€11.10
Summary
This prediction is currently active. The prediction currently has a performance of 11.32%. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -0.893% | -0.893% |
| iShares Core DAX® | -0,37 % | 8,40 % |
| iShares Nasdaq 100 | 2,27 % | 15,23 % |
| iShares Nikkei 225® | 1,43 % | 14,42 % |
| iShares S&P 500 | 1,22 % | 10,49 % |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.60
02.09.25
02.09.25
€20.51
02.09.26
02.09.26
46.05%
28.04.26
28.04.26
